Xeloda(R) Combination Meets Primary Endpoint In International Phase III Advanced Colorectal Cancer Study
Sun, 24 Dec 2006 08:00 AM EST
... Roche announced today that a large, international Phase III study (NO16967) of 627 previously treated patients with advanced colorectal cancer met its primary endpoint of progression-free survival. [click link for full article] ...
Related Topics
- Colorectal Cancer
- Capecitabine
- Primary
- Primary Care
- Prostate Cancer
- Antithrombin III
- Rectal Cancer
- International Health
- Thyroid Cancer
- Metastatic Cancer
- Cancer, Colorectal
- Colorectal Cancer, Childhood
- Clinical Trials
- Hereditary nonpolyposis colorectal cancer
- Pulmonary Hypertension
- Hepatocellular
- Familial Dysautonomia
- Radiotherapy
- Lymphedema
- Combination Vaccines

Not Signed In -


